National Heart, Lung, and Blood Institute Clinical Proteomics Working Group Report
Authors:
- Jennifer E. Van EykJEJennifer E. Van Eyk
- Stephen C. MockrinSMStephen C. Mockrin
- N. Leigh AndersonNAN. Leigh Anderson
- 13 April 2004
- journal article
- congress
- Published by Wolters Kluwer Health in Circulation
- Vol. 109 (14) , 1697-1703
Abstract
The National Heart, Lung, and Blood Institute (NHLBI) Clinical Proteomics Working Group was charged with identifying opportunities and challenges in clinical proteomics and using these as a basis for recommendations aimed at directly improving patient care. The group included representatives of clinical and translational research, proteomic technologies, laboratory medicine, bioinformatics, and 2 of the NHLBI Proteomics Centers, which form part of a program focused on innovative technology development. This report represents the results from a one-and-a-half-day meeting on May 8 and 9, 2003. For the purposes of this report, clinical proteomics is defined as the systematic, comprehensive, large-scale identification of protein patterns (“fingerprints”) of disease and the application of this knowledge to improve patient care and public health through better assessment of disease susceptibility, prevention of disease, selection of therapy for the individual, and monitoring of treatment response.Keywords
This publication has 7 references indexed in Scilit:
- Prospective analysis of creatine kinase muscle-brain fraction and comparison with troponin T to predict cardiac risk and benefit of an invasive strategy in patients with non–ST-elevation acute coronary syndromesJACC, 2002
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- Multimarker Approach to Risk Stratification in Non-ST Elevation Acute Coronary SyndromesCirculation, 2002
- Use of proteomic patterns in serum to identify ovarian cancerThe Lancet, 2002
- Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspneaJACC, 2002
- Bedside Multimarker Testing for Risk Stratification in Chest Pain UnitsCirculation, 2001
- Markers of Myocardial Damage and Inflammation in Relation to Long-Term Mortality in Unstable Coronary Artery DiseaseNew England Journal of Medicine, 2000